Skip to content
    JBTM
    Earnings call· Dec 2025(Q4 FY25)

    JBT MAREL Q4 FY25 earnings call JBTM

    Feb 24, 2026 Source

    Executive summary

    JBT Marel Q4 FY25 — Strong Integration and Exceeded Deleveraging Target

    JBT Marel completed its first year as a combined entity, demonstrating successful integration with strong revenue growth and significant margin expansion. The company exceeded its deleveraging target and achieved adjusted EPS accretion, driven by robust protein demand and synergy realization. Despite tariff headwinds and some segment-specific challenges, management is optimistic about continued growth and margin progression, with a focus on strategic integration and capital efficiency.

    Highlights

    5

    • Achieved adjusted EPS accretion in the first year, with FY25 adjusted EPS of $6.41 compared to legacy JBT's FY24 adjusted EPS of $6.15.

    • Exceeded targeted deleveraging, ending FY25 with a leverage ratio of less than 2.9x against a goal of 3x.

    • Realized $43 million in year-over-year synergy benefits in FY25, exiting the year with an $85 million run rate.

    • Captured $30 million in order synergies for the full year, with more than half realized in Q4 FY25.

    • Full year consolidated revenue of $3.8 billion exceeded the high end of guidance.

    Concerns

    4

    • Experienced a higher tariff environment since April 2025, resulting in a $43 million cost to JBT Marel for the year (net of $15 million cost avoidance).

    • Tariffs had an approximate 50 basis point impact on adjusted EBITDA margins in 2025.

    • Fourth quarter adjusted EBITDA margin of 16% declined sequentially due to the acceleration of tariff costs and investments.

    • Faced challenges primarily on the AGV side, impacting the Prepared Food & Beverage Solutions segment in Q4 2025, with some bleed expected into early Q2 2026.

    Guidance & targets

    11
    CategoryTargetConfidence
    Full year 2026 Consolidated Revenue Growth
    5% to 7%
    high materiality
    High
    Full year 2026 Adjusted EBITDA Margins
    17% to 17.5%
    high materiality
    High
    Full year 2026 Adjusted Earnings Per Share
    $8 to $8.50
    high materiality
    High
    Full year 2026 GAAP Earnings Per Share
    $4.70 to $5.15
    medium materiality
    High
    Q1 2026 Revenue
    $920 million to $940 million
    medium materiality
    High
    Q1 2026 Adjusted EBITDA Margin
    14% to 15%
    medium materiality
    High
    Full year 2026 Synergy Savings (year-over-year benefit)
    $60 million
    medium materiality
    High
    Full year 2026 Tariff Costs (before pricing actions)
    $45 million higher
    high materiality
    Medium
    Leverage Ratio Target
    2x to 2.5x
    high materiality
    High
    Run Rate Synergy Savings
    $150 million
    high materiality
    High
    Cumulative Revenue Synergies
    Ahead of pace on original $75 million
    medium materiality
    High

    Segment performance

    2
    SegmentRevenueYoYQoQMargin
    Protein Solutions
    Full year 2025 revenue. Adjusted EBITDA margin for the full year 2025. Expected to grow at the higher end of the 5-7% consolidated revenue range in 2026, with anticipated margin improvement.
    		$1.7 billion——20.1% adjusted EBITDA margin
    Prepared Food & Beverage Solutions
    Full year 2025 revenue. Adjusted EBITDA margin for the full year 2025. Expected to grow at the lower end of the 5-7% consolidated revenue range in 2026, with anticipated margin improvement, slightly higher than Protein Solutions due to addressing Q4 2025 issues.
    		$2.1 billion——17.2% adjusted EBITDA margin

    Operational metrics

    11
    Consolidated Adjusted EBITDA
    $600 million
    FY25

    At the midpoint of guidance.

    Synergy Savings (year-over-year benefit)
    $43 million
    FY25

    Primarily driven by streamlining organizational structure, optimizing public company and third-party costs, and consolidating spend with supply base.

    Run Rate Synergy Savings
    $85 million
    Exit FY25

    Versus 2024 baseline.

    Tariff Cost
    $43 million
    FY25

    Impacted by higher tariff environment since April 2025.

    Adjusted EPS
    $6.41accretion vs $6.15
    FY25

    Represents first year earnings accretion relative to legacy JBT's 2024 adjusted earnings of $6.15 per share.

    Leverage Ratio
    <2.9xvs goal of 3x
    End FY25

    Demonstrates earnings and cash flow power of the combined company.

    Foreign Exchange Translation Impact on Revenue
    $77 million
    FY25

    In line with expectations.

    Poultry Orders Split
    75%
    FY25

    Of total poultry orders, 75% goes to Protein Solutions segment.

    Poultry Orders Split
    25%
    FY25

    Of total poultry orders, 25% goes to Prepared Food & Beverage Solutions segment.

    Net Negative Tariff Impact on Adjusted EBITDA Margins
    25-50 bps
    FY26

    Expected for the full year, depending on market status and pricing actions.

    R&D Accounting Harmonization
    —
    Q4 FY25

    Legacy JBT's R&D was in cost of goods sold, Marel's was in one spot. Harmonized in Q4 2025 for apples-to-apples comparison going forward.

    Industry KPIs

    3
    MetricValueDetails
    Tariff cost impact$43 millionUSD
    Parts aftermarket businessSolid demand
    Order backlog order intake by segment$3.8 billionUSD

    Orderbook & backlog

    3
    Full Year Orders$3.8 billionFY25
    Q4 Orders>$1 billionQ4 FY25
    Order Synergies$30 millionFY25

    More than half realized in Q4 FY25. Expected to convert to revenue in 2026.

    Product announcements

    1
    ProductTypeDetails
    Integrated Solutionsmilestone

    Risks & headwinds

    2
    Higher Tariff EnvironmentFY25, FY26

    $43 million cost in FY25 (net of $15 million avoidance); ~50 bps impact on adjusted EBITDA margins in FY25. Expected $45 million higher costs in FY26 before pricing actions.

    Mitigation: Supply chain regionalization (moving parts suppliers from Europe to U.S., manufacturing regionalization through 2026-2027), selective pricing actions, cost avoidance through supplier negotiations.

    Challenges in AGV BusinessQ4 FY25, Q1-Q2 FY26

    Impacted Prepared Food & Beverage Solutions segment in Q4 FY25.

    Mitigation: Expect issues to be relatively contained through Q1 and early Q2 2026, with efforts to correct issues and improve flow-through.

    What to watch in Q1 FY26

    5

    AGV Segment Recovery

    Q1 FY26 / Q2 FY26
    CurrentChallenges in Q4 FY25, expected to bleed into early Q2 FY26
    TargetImproved performance and recovery

    Why it matters

    Recovery in the AGV segment is crucial for the performance of the Prepared Food & Beverage Solutions segment and overall revenue growth.

    But we expect to see our ability through that -- those issues through Q1 and early Q2. So it should be relatively contained the first quarter, maybe a little bit bleed into the early part of the second quarter.

    Q&A highlights

    8

    What end markets drove Q4 order performance, especially given AGV being flat and fruit & vegetable being down?

    Poultry remained the strongest category, followed by beverages. Meat and fish were supportive, and pet food showed momentum. AGV is expected to recover in 2026. Poultry orders split 75% to Protein Solutions and 25% to Prepared Food & Beverage Solutions.

    “I would say, generally speaking, poultry remains the leader across all of our categories. and I would say, followed by beverages in 2020 -- as we ended the year 2025. Meat remains supportive as does fish. And we're starting to see some real momentum on the pet food side as well. And as you suggested, we do expect a nice recovery in AGV as we go into next year.”

    asked by Ross Sparenblek · answered by Brian Deck

    2 min read5 chapters

    Detailed Narrative

    01

    Successful Integration and Synergy Realization

    JBT Marel completed its first year post-merger, demonstrating strong execution on integration plans. The company realized $43 million in year-over-year synergy benefits in 2025, exiting the year with an $85 million run rate. Management expressed confidence in achieving the goal of $150 million in run rate synergy savings by the end of 2027, driven by organizational streamlining, cost optimization, and supply chain consolidation. Order synergies also accelerated, reaching $30 million for the full year, with over half in Q4.

    02

    Robust Demand in Protein End Markets

    The company benefited from a diversified portfolio and strong end-market exposure, with full-year orders of $3.8 billion and over $1 billion in Q4. This performance was primarily led by exceptional strength in protein end markets, particularly poultry, which saw a sharp recovery after two years of underinvestment. Meat, beverages, and pharma also contributed to growth, while Prepared Foods showed improvement in Q4. Geographically, JBT Marel experienced gains across all regions in 2025.

    03

    Tariff Headwinds and Mitigation Efforts

    JBT Marel faced significant tariff headwinds🌐, incurring approximately $43 million in costs in 2025, net of $15 million in cost avoidance. These tariffs impacted adjusted EBITDA margins by about 50 basis points for the year. For 2026, the company forecasts approximately $45 million in higher tariff costs before pricing actions, with most of the increase in the first half. Management is implementing supply chain regionalization and selective pricing actions to mitigate these impacts, aiming for a net negative impact of 25-50 basis points on EBITDA margins for 2026.

    04

    Strong Financial Performance and Deleveraging

    The company reported full-year consolidated revenue of $3.8 billion, exceeding guidance, and adjusted EBITDA of $600 million, representing a 15.8% margin. Adjusted EPS for 2025 was $6.41, demonstrating accretion relative to legacy JBT's 2024 adjusted EPS of $6.15. JBT Marel also successfully deleveraged its balance sheet, ending 2025 with a leverage ratio below 2.9x, surpassing its goal of 3x. The company aims to reach a leverage ratio of 2x to 2.5x by the end of 2026.

    05

    Segment Performance and Outlook

    The new segment reporting structure includes Protein Solutions and Prepared Food & Beverage Solutions. Protein Solutions reported $1.7 billion in revenue and a 20.1% adjusted EBITDA margin for 2025, while Prepared Food & Beverage Solutions had $2.1 billion in revenue and a 17.2% adjusted EBITDA margin. For 2026, Protein Solutions is expected to grow at the higher end of the 5-7% consolidated revenue range, with Prepared Food & Beverage Solutions at the lower end. Both segments are projected to see margin improvement, with Prepared Food & Beverage showing slightly higher improvement due to addressing Q4 challenges in the AGV sector.

    AI-generated summary of the company’s earnings call. Not investment advice.